Skip to main content
Amphastar Pharmaceuticals, Inc. (AMPH)
NASDAQ: AMPH · Real-Time Price · USD
21.82
+0.17 (0.79%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Amphastar Pharmaceuticals Revenue

In the year 2025, Amphastar Pharmaceuticals had annual revenue of $719.89M, down -1.65%. Amphastar Pharmaceuticals had revenue of $183.11M in the quarter ending December 31, 2025, a decrease of -1.83%.

Revenue (ttm)
$719.89M
Revenue Growth
-1.65%
P/S Ratio
1.36
Revenue / Employee
$364,315
Employees
1,976
Market Cap
971.75M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025719.89M-12.08M-1.65%
Dec 31, 2024731.97M87.57M13.59%
Dec 31, 2023644.40M145.41M29.14%
Dec 31, 2022498.99M61.22M13.98%
Dec 31, 2021437.77M87.92M25.13%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Perrigo Company 4.25B
Evotec SE 925.65M
Tilray Brands 858.28M
Collegium Pharmaceutical 780.57M
Pacira BioSciences 726.41M
Alvotech 588.90M
Ironwood Pharmaceuticals 296.15M
Harrow 272.30M
Revenue Rankings

AMPH News

More News